Redmile Group, LLC Gilead Sciences, Inc. Transaction History

Redmile Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $137 Million - $157 Million	-2,288,846 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $32.9 Million - $37.5 Million	-581,116 Reduced 20.25%	2,288,846 $133 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $178 Million - $224 Million	2,869,962 New	2,869,962 $181 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.